Get started
Author

Mark Kačar

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021 · Eugenia Abaleke, Mustafa Abbas, et al. · The Lancet · 533
PDF
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
2021 · Obbina Abani, Ali Abbas, et al. · The Lancet · 493
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2022 · Obbina Abani, Ali Abbas, et al. · The Lancet · 369
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
2022 · Obbina Abani, Ali Abbas, et al. · The Lancet · 324
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021 · Obbina Abani, Ali Abbas, et al. · The Lancet · 290
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
2023 · Obbina Abani, Ali Abbas, et al. · The Lancet · 129
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2023 · O Abani, A Abbas, et al. · The Lancet Diabetes & Endocrinology · 41
PDF
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial
2024 · Saul N Faust, Richard Haynes, et al. · The Lancet Child & Adolescent Health · 39
PDF
The Efficacy, Safety and Tolerability of Canakinumab in the Treatment of Familial Mediterranean Fever: A Systematic Review of the Literature
2020 · Mark Kacar, Sinisa Savic, et al. · Journal of Inflammation Research · 38
PDF
High burden of clonal mast cell disorders and hereditary α‐tryptasemia in patients who need Hymenoptera venom immunotherapy
2024 · Peter Korošec, Gunter J. Sturm, et al. · Allergy · 37
PDF
Clonal mast cell disorders and hereditary α‐tryptasemia as risk factors for anaphylaxis
2023 · Mark Kačar, Matija Rijavec, et al. · Clinical & Experimental Allergy · 37
PDF
Somatic Mutations and the Risk of Undifferentiated Autoinflammatory Disease in MDS: An Under-Recognized but Prognostically Important Complication
2021 · Abdulla Watad, Mark Kacar, et al. · Frontiers in Immunology · 35
PDF
Hereditary systemic autoinflammatory diseases and Schnitzler’s syndrome
2019 · Mark Kacar, Shelly Pathak, et al. · Lara D. Veeken · 35
PDF
Mixed results with baricitinib in biological-resistant adult-onset Still’s disease and undifferentiated systemic autoinflammatory disease
2020 · Mark Kacar, John Fitton, et al. · RMD Open · 29
PDF
Phenotypic analysis of pyrin-associated autoinflammation with neutrophilic dermatosis patients during treatment
2021 · Erika Van Nieuwenhove, Ellen De Langhe, et al. · Lara D. Veeken · 14
PDF
Evidence of B Cell Clonality and Investigation Into Properties of the IgM in Patients With Schnitzler Syndrome
2020 · Shelly Pathak, Dorota Rowczenio, et al. · Frontiers in Immunology · 13
PDF
Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases · 12
PDF
Contact Urticaria and Related Conditions: Clinical Review
2025 · Mojca Bizjak, Olivier Aerts, et al. · Contact Dermatitis · 12
Autoimmune and autoinflammatory manifestations in inborn errors of immunity
2022 · Mark Kačar, Gašper Markelj, et al. · Current Opinion in Allergy and Clinical Immunology · 9
The Scope and Impact of Viral Infections in Common Variable Immunodeficiency (CVID) and CVID-like Disorders: A Literature Review
2024 · Adam Al-Hakim, Mark Kacar, et al. · Journal of Clinical Medicine · 8
PDF
Identification of Critical Transcriptomic Signaling Pathways in Patients with H Syndrome and Rosai-Dorfman Disease
2020 · Samuel Lara-Reyna, James A. Poulter, et al. · Journal of Clinical Immunology · 8
PDF
Neutralizing Anti-interferon-γ Autoantibodies: an Ameliorating Factor in COVID-19 Infection?
2021 · Mark Kacar, Paulina Cortes-Acevedo, et al. · Journal of Clinical Immunology · 6
PDF
Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
2025 · O. Abani, A. Abbas, et al. · EClinicalMedicine · 5
Length of hospital stay and survival of hospitalized COVID-19 patients during the second wave of the pandemic: A single centre retrospective study from Slovenia
2022 · Aleš Rozman, Boštjan Rituper, et al. · Slovenian Journal of Public Health · 5
PDF
Selective Response to Omalizumab in a Patient With Concomitant ncMCAS and POTS: What Does it Teach us About the Underlying Disease?
2018 · M Kacar, S Denman, et al. · Journal of Investigational Allergology and Clinical Immunology · 5
PDF
Works count: 44
Citation count: 2,528
H-index: 14
I10-index: 18
Year
Topic
Type